Literature DB >> 33823562

Pregnancy outcomes among Asian Americans of advanced maternal age, 1992-2018.

Deepa Dongarwar1, Danyal Tahseen2, Muktar H Aliyu3, Hamisu M Salihu1,4.   

Abstract

AIM: The trend of delayed childbearing has implications for the increasing national burden of adverse perinatal outcomes across vulnerable racial-ethnic groups. The objective of this study was to investigate age-adjusted risk for adverse maternal-fetal outcomes among Asian Americans of advanced maternal age (≥35 years).
METHODS: This was a retrospective cohort study using the 1992-2018 Natality data files. We calculated the prevalence of maternal-fetal outcomes: maternal diabetes, hypertensive disorders of pregnancy (HDP), C-section, small-for-gestational age (SGA), large-for-gestational age (LGA), and preterm birth. Adjusted binomial logistic regression was created to evaluate the association between maternal race/ethnicity and each of the maternal-fetal outcomes.
RESULTS: Compared with non-Hispanic Whites, Asian American women had reduced odds of diabetes, HDP, and LGA babies and increased odds of preterm birth, C-section delivery, and SGA, irrespective of the advanced maternal age group. The odds of developing specific adverse outcomes by advanced maternal age varied by Asian American ethnic subgrouping. DISCUSSION: The risk of maternal-fetal outcomes varied among the ethnic subgroups of Asian Americans in the United States. Future studies should explore the sociocultural and environmental nuances that might explain these differences.
© 2021 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Asian Americans; C-section; LGA; SGA; diabetes; hypertension; preterm birth

Year:  2021        PMID: 33823562     DOI: 10.1111/jog.14790

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  1 in total

1.  Impact of Maternal Age on Singleton Pregnancy Outcomes in Primiparous Women in South Korea.

Authors:  Eui Hyeok Kim; Jaekyung Lee; Sang Ah Lee; Yong Wook Jung
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.